Drug-induced megaloblastic anemias
Stebbins, R.; Scott, J.; Herbert, V.
Seminars in Hematology 10(3): 235-251
1973
ISSN/ISBN: 0037-1963 PMID: 4577647 Document Number: 67602
Document emailed within 1 workday
Related Documents
Pribilla, W. 1973: Megaloblastic anemias Die Medizinische Welt 24(17): 670-672Leibetseder, F. 1971: Toxic and drug-induced hemolytic anemias Wiener Medizinische Wochenschrift 121(45): 813-815
Maas, D.; Schubothe, H.; Weber, S. 1974: Hemolytic anemias induced by drug hypersensitivity Folia Haematologica 101(3): 372-383
Donhuijsen-Ant, R.; Wellens, W.; Westerhausen, M. 1982: Morphologic, cytochemical and biochemical findings in megaloblastic anemias. Considerations and differential diagnosis Die Medizinische Welt 33(25): 924-925
Berliner, G.B.; Kheĭfets, L.M. 1994: The characteristics of iron metabolism in B12-deficient anemias (an evaluation of the functional status of megaloblastic erythropoiesis) Terapevticheskii Arkhiv 66(7): 58-61
Cristoffanini, A.P.; Ibarra, H.; Vega, I.; Martínez, A.; Bertoglio, J.C. 1976: Diphyllobothrium latum induced megaloblastic anemia Revista Medica de Chile 104(12): 921-924
López, R.; Cuquet, J.; Fitó, R.; Pujol, R. 1988: Sulfasalazine-induced megaloblastic anemia in rheumatoid arthritis Medicina Clinica 91(14): 559
Fleischhacker, H. 1972: Extraerythrocyte induced hemolytic anemias Wiener Medizinische Wochenschrift 122(1): 12-14
Balbi, C.; D'Ajello, M.; Nappa, L. 1979: Clinical study of a drug containing the chondroitin-sulfonic ferric acid complex in iron-deficiency anemias in the puerperium Minerva Ginecologica 31(11): 821-824
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Nigen, S.; Knowles, S.R.; Shear, N.H. 2003: Drug eruptions: approaching the diagnosis of drug-induced skin diseases Journal of Drugs in Dermatology: Jdd 2(3): 278-299
Bach, O.; Kästner, I. 1984: Undesired drug side effects and drug-induced damage. II. Centrally acting drugs Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 39(1): 1-6
Koriakin, V.A.; Sokolova, G.B.; Ziia, A.V.; Zeliger, L.R.; Ivleva, A.Ia. 1987: Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients Terapevticheskii Arkhiv 59(7): 75-77
Jennum, P.; Kristensen, M.B. 1985: Drug-induced blood dyscrasias. Reports to the Committee on Adverse Drug Reactions 1968-1983 Ugeskrift for Laeger 147(32): 2539-2541
Llau, M.E.; Nguyen, L.; Senard, J.M.; Rascol, O.; Montastruc, J.L. 1994: Drug-induced Parkinson syndrome: 10 years of drug vigilance Therapie 49(5): 459-460
Kourounakis, P.N.; Rekka, E.; Hadjipetrou-Kourounakis, L. 1991: Restoration of impaired drug metabolism of rats with adjuvant induced disease by two steroids with different influence on drug biotransformation Die Pharmazie 46(10): 727-729
Idel'son, L.I. 1978: Megaloblastic anemia Terapevticheskii Arkhiv 50(7): 48
Hift, W.; Moshal, M.G. 1978: Multifactorial megaloblastic anaemia South African Medical Journal 53(8): 275-282
Kölblová, V.; Neuwirthová, R.; Labohá, J.; Vedra, B. 1983: Megaloblastic anemia in pregnancy Ceskoslovenska Gynekologie 48(5): 369-371
Lawson, D.H.; Murray, R.M.; Parker, J.L.; Hay, G. 1970: Hypokalaemia in megaloblastic anaemias Lancet 2(7673): 588-590